re: Ann: Mesoblast Reports Positive Type 2 Di... I,
This ASX release has Silviu all over it.
In my opinion very good outcome but as I have said many times before ..this is the nature of the man..he lets his actions(clinical outcomes) speak louder than his words.
BUT Take note of this statement:
"According to the United States Food and Drug Administration Guidance for Industry 2008, HbA1c is the primary endpoint of choice for glycemic control in subjects with type 2 diabetes".
Let me read b/w the lines...when that bank was going on about how terrible the CHF results were(due to Ejection Faction criteria) the Professor said all along that its MACE and Cardiac events that FDA look at. So from my perspective todays annoucement is an insight to where TD2 is heading.
My view only. GLTAH
(ps: Looking fwd to Analyst reports for more detail).
re: Ann: Mesoblast Reports Positive Type 2 Di... I,This ASX...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |